Authors:
LACOMBE L
DALBAGNI G
ZHANG ZF
CORDONCARDO C
FAIR WR
HERR HW
REUTER VE
Citation: L. Lacombe et al., OVEREXPRESSION OF P53 PROTEIN IN A HIGH-RISK POPULATION OF PATIENTS WITH SUPERFICIAL BLADDER-CANCER BEFORE AND AFTER BACILLUS-CALMETTE-GUERIN THERAPY - CORRELATION TO CLINICAL OUTCOME, Journal of clinical oncology, 14(10), 1996, pp. 2646-2652
Citation: Hw. Herr et S. Hilton, ROUTINE CT SCAN IN CYSTECTOMY PATIENTS - DOES IT CHANGE MANAGEMENT (VOL 47, PG 324, 1996), Urology, 47(5), 1996, pp. 785-785
Citation: Hw. Herr et al., UPPER TRACT TUMORS IN PATIENTS WITH PRIMARY BLADDER-CANCER FOLLOWED FOR 15 YEARS, The Journal of urology, 156(4), 1996, pp. 1286-1287
Authors:
DONAT SM
HERR HW
BAJORIN DF
FAIR WR
SOGANI PC
RUSSO P
SHEINFELD J
SCHER HI
Citation: Sm. Donat et al., METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN CHEMOTHERAPY ANDCYSTECTOMY FOR UNRESECTABLE BLADDER-CANCER, The Journal of urology, 156(2), 1996, pp. 368-371
Authors:
ARONSON DC
MEDARY I
FINLAY JL
HERR HW
EXELBY PR
LAQUAGLIA MP
Citation: Dc. Aronson et al., RENAL-CELL CARCINOMA IN CHILDHOOD AND ADOLESCENCE - A RETROSPECTIVE SURVEY FOR PROGNOSTIC FACTORS IN 22 CASES, Journal of pediatric surgery, 31(1), 1996, pp. 183-186
Authors:
JONES GT
METTLIN C
MURPHY GP
GUINAN P
HERR HW
HUSSEY HD
CHMIEL JS
FREMGEN AM
CLIVE RE
ZUBEROCWIEJA KE
WINCHESTER DP
Citation: Gt. Jones et al., PATTERNS OF CARE FOR CARCINOMA OF THE PROSTATE-GLAND - RESULTS OF A NATIONAL SURVEY OF 1984 AND 1990, Journal of the American College of Surgeons, 180(5), 1995, pp. 545-554
Authors:
SARKIS AS
BAJORIN DF
REUTER VE
HERR HW
NETTO G
ZHANG ZF
SCHULTZ PK
CORDONCARDO C
SCHER HI
Citation: As. Sarkis et al., PROGNOSTIC VALUE OF P53 NUCLEAR OVEREXPRESSION IN PATIENTS WITH INVASIVE BLADDER-CANCER TREATED WITH NEOADJUVANT MVAC, Journal of clinical oncology, 13(6), 1995, pp. 1384-1390
Citation: Hw. Herr et al., INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY PREVENTS TUMOR PROGRESSION AND DEATH FROM SUPERFICIAL BLADDER-CANCER - 10-YEAR FOLLOW-UP OF APROSPECTIVE RANDOMIZED TRIAL, Journal of clinical oncology, 13(6), 1995, pp. 1404-1408
Authors:
HILTON S
TEITCHER JB
BEGG CB
HERR HW
CASTELLINO RA
Citation: S. Hilton et al., CT FOR DETECTION OF RETROPERITONEAL LYMPH-NODE METASTASIS IN PATIENTSWITH CLINICAL STAGE-I TESTICULAR NONSEMINOMATOUS GERM-CELL CANCER - ASSESSMENT OF SIZE CRITERIA, Radiology, 197, 1995, pp. 286-286
Citation: Hw. Herr, APPARENT FAILURE OF CURRENT INTRAVESICAL CHEMOTHERAPY PROPHYLAXIS TO INFLUENCE THE LONG-TERM COURSE OF SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - COMMENTS, The Journal of urology, 153(5), 1995, pp. 1450-1450
Authors:
BEGG CB
ZHANG ZF
SUN M
HERR HW
SCHANTZ SP
Citation: Cb. Begg et al., METHODOLOGY FOR EVALUATING THE INCIDENCE OF 2ND PRIMARY CANCERS WITH APPLICATION TO SMOKING-RELATED CANCERS FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, American journal of epidemiology, 142(6), 1995, pp. 653-665
Authors:
ZHANG ZF
SARKIS AS
CORDONCARDO C
DALBAGNI G
MELAMED J
APRIKIAN A
POLLACK D
SHEINFELD J
HERR HW
FAIR WR
REUTER VE
BEGG C
Citation: Zf. Zhang et al., TOBACCO SMOKING, OCCUPATION, AND P53 NUCLEAR OVEREXPRESSION IN EARLY-STAGE BLADDER-CANCER, Cancer epidemiology, biomarkers & prevention, 3(1), 1994, pp. 19-24
Authors:
SCHULTZ PK
HERR HW
ZHANG ZF
BAJORIN DF
SEIDMAN A
SARKIS A
FAIR WR
SCHERR D
BOSL GJ
SCHER HI
Citation: Pk. Schultz et al., NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER-CANCER - PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED WITH M-VAC WITH 5-YEAR FOLLOW-UP, Journal of clinical oncology, 12(7), 1994, pp. 1394-1401
Citation: Hw. Herr et Hi. Scher, NEOADJUVANT CHEMOTHERAPY AND PARTIAL CYSTECTOMY FOR INVASIVE BLADDER-CANCER, Journal of clinical oncology, 12(5), 1994, pp. 975-980
Authors:
SCHWALB MD
HERR HW
SOGANI PC
RUSSO P
SHEINFELD J
FAIR WR
Citation: Md. Schwalb et al., POSITIVE URINARY CYTOLOGY FOLLOWING A COMPLETE RESPONSE TO INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY - PATTERN OF RECURRENCE, The Journal of urology, 152(2), 1994, pp. 382-387
Authors:
SARKIS AS
DALBAGNI G
CORDONCARDO C
MELAMED J
ZHANG ZF
SHEINFELD J
FAIR WR
HERR HW
REUTER VE
Citation: As. Sarkis et al., ASSOCIATION OF P53 NUCLEAR OVEREXPRESSION AND TUMOR PROGRESSION IN CARCINOMA IN-SITU OF THE BLADDER, The Journal of urology, 152(2), 1994, pp. 388-392
Citation: Be. Davis et al., THE MANAGEMENT OF PATIENTS WITH NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS WITH SEROLOGIC DISEASE ONLY AFTER ORCHIECTOMY, The Journal of urology, 152(1), 1994, pp. 111-113